Literature DB >> 822117

X-linked B-lymphocyte defect in CBA/N mice. III. Abnormal development of B-lymphocyte populations defined by their density of surface immunoglobulin.

I Scher, S O Sharrow, W E Paul.   

Abstract

CBA/N mice have an X-linked defect in B-lymphocyte function characterized by a failure to respond to certain thymus-independent antigens. When studied by rapid flow microfluorometry, adult CBA/N splenic B lymphocytes labeled with either fluorescein-conjugated (Fl) anti-Ig or Fl anti-mu had fluorescence profiles which were considerably different from those of B lymphocytes derived from normal mice. By studying progeny of crosses of CBA/N and normal mice, it was shown that the abnormal fluorescence profiles of CBA/N B cells were determined by an X-linked gene. The fluorescence profile of adult CBA/N splenic B lymphocytes labeled with anti-mu were very similar to the patterns of neonatal normal and of neonatal CBA/N splenic B lymphocytes suggesting that the defect of CBA/N mice is due to a failure in the development of a mature B-lymphocyte population. The fluorescence profiles of adult CBA/N splenic B lymphocytes labeled with Fl anti-Ig also had immature characteristics in that the frequency of cells with large amounts of surface immunoglobulin was increased in comparison to that of normal strains and the population of cells with low-to-intermediate density of total surface immunoglobulin, which appear characteristic of normal adult splenic B lymphocytes, was markedly diminished.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 822117      PMCID: PMC2190384          DOI: 10.1084/jem.144.2.507

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  The genetics of the immune response to a synthetic double-stranded RNA in a mutant CBA mouse strain.

Authors:  I Scher; M M Frantz; A D Steinberg
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

2.  Analysis of cell populations with a fluorescence-activated cell sorter.

Authors:  M R Loken; L A Herzenber
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

3.  X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect.

Authors:  I Scher; A D Steinberg; A K Berning; W E Paul
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

4.  X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells.

Authors:  I Scher; A Ahmed; D M Strong; A D Steinberg; W E Paul
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

5.  Abnormal ratio of membrane immunoglobulin classes in mice with an X-linked B-lymphocyte defect.

Authors:  F D Finkelman; A H Smith; I Scher; W E Paul
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

6.  Cell surface immunoglobulin. XI. The appearance of an IgD-like molecule on murine lymphoid cells during ontogeny.

Authors:  E S Vitetta; U Melcher; M McWilliams; M E Lamm; J M Phillips-Quagliata; J W Uhr
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

7.  B-lymphocyte heterogeneity: ontogenetic development and organ distribution of B-lymphocyte populations defined by their density of surface immunoglobulin.

Authors:  I Scher; S O Sharrow; R Wistar; R Asofsky; W E Paul
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

8.  Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness.

Authors:  D F Amsbaugh; C T Hansen; B Prescott; P W Stashak; D R Barthold; P J Baker
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

  8 in total
  27 in total

1.  B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens.

Authors:  A Ahmed; I Scher; S O Sharrow; A H Smith; W E Paul; D H Sachs; K W Sell
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

2.  Endotoxin lethality and tolerance in mice: analysis with the B-lymphocyte-defective CBA/N strain.

Authors:  N M Zaldivar; I Scher
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

3.  Respiratory syncytial virus infection in inbred mice.

Authors:  G A Prince; R L Horswood; J Berndt; S C Suffin; R M Chanock
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

4.  Partial suppression of anchorage-independent growth and tumorigenicity in immunodeficient mice by transfection of the H-2 class I gene H-2Ld into a human colon cancer cell line (HCT).

Authors:  S Gattoni-Celli; C G Willett; D B Rhoads; B Simon; R M Strauss; K Kirsch; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA.

Authors:  B J Steinberg; P A Smathers; K Frederiksen; A D Steinberg
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

6.  Characterization of immunogenic properties of haptenated liposomal model membranes in mice. VII. Synergistic responses to haptenated liposomes and haptenated thymus-dependent antigens in CBA/N mice.

Authors:  H Snippe; A J Van Houte; A Janssen; E F Lizzio; J M Willers; B Merchant
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

7.  Characterization of immunogenic properties of haptenated liposomal model membranes in mice. VI. Response in B-cell-defective CBA/N mice.

Authors:  H Snippe; A J van Houte; E F Lizzio; J M Willers; B Merchant
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

8.  New phenotypic marker for lipopolysaccharide responsiveness.

Authors:  S V Gollapudi; S H Gregory; M Kern
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

9.  Polyclonal B-cell response to stimulation with Escherichia coli lipopolysaccharide in dietary protein restriction.

Authors:  I Malavé; M Pocino
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

10.  Hapten-specific B cell blockade of the immune response to a thymus-independent-1 antigen produced by concomitant administration of a thymus-independent-2 antigen.

Authors:  H Snippe; A J Van Houte; J K Inman; E F Lizzio; B Merchant
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.